STRATA Skin Sciences, Inc.
STRATA Skin Sciences, Inc.
Your view on SSKN
Overview
What the company does, where it operates, and who runs it.
About STRATA Skin Sciences, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Dolev Rafaeli
- Headquarters
- 5 Walnut Grove Drive, Horsham, PA, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Dolev Rafaeli
- Headquarters
- 5 Walnut Grove Drive, Horsham, PA, US
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.
The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions.
The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for STRATA Skin Sciences, Inc., and the rating behind it. SSKN last traded at $1.38; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for STRATA Skin Sciences, Inc.. Starting points for STRATA Skin Sciences, Inc.: EPS -$1.10, beta 0.49 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for STRATA Skin Sciences, Inc.. STRATA Skin Sciences, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for STRATA Skin Sciences, Inc.. Trailing twelve-month EPS for STRATA Skin Sciences, Inc. stands at -$1.10. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for STRATA Skin Sciences, Inc.. STRATA Skin Sciences, Inc. has reported as a listed company since 2005. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
STRATA Skin Sciences, Inc. valued side by side against its closest peers. STRATA Skin Sciences, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold STRATA Skin Sciences, Inc., and how their positions are changing. At a $5.9M market value, institutional positions materially move STRATA Skin Sciences, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by STRATA Skin Sciences, Inc. executives and directors. Shares of STRATA Skin Sciences, Inc. have traded between $1.33 and $3.86 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming STRATA Skin Sciences, Inc.. STRATA Skin Sciences, Inc. is a $5.9M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming STRATA Skin Sciences, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for STRATA Skin Sciences, Inc.. Coverage tracks STRATA Skin Sciences, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.